The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes
Author:
Funder
Seventh Framework Programme
Publisher
Elsevier BV
Subject
Organic Chemistry,Biochemistry,Clinical Biochemistry
Reference98 articles.
1. Targeting RAGE signaling in inflammatory disease;Hudson;Annu. Rev. Med.,2018
2. RAGE regulation and signaling in inflammation and beyond;Kierdorf;J. Leukoc. Biol.,2013
3. The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways;Prantner;Faseb. J.,2020
4. Soluble RAGEs - prospects for treating & tracking metabolic and inflammatory disease;Schmidt;Vasc. Pharmacol.,2015
5. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?;Prasad;Mol. Cell. Biochem.,2019
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A multifunctional injectable hydrogel for boosted diabetic wound healing assisted by Quercetin-ZIF system;Chemical Engineering Journal;2024-09
2. Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review;Pharmacological Research;2024-08
3. Soluble RAGE attenuates myocardial I/R injury by suppressing interleukin-6;The American Journal of the Medical Sciences;2024-08
4. Pre‐diagnostic plasma advanced glycation end‐products and soluble receptor for advanced glycation end‐products and mortality in colorectal cancer patients;International Journal of Cancer;2024-07-26
5. The effect of a combined lifestyle intervention with and without protein drink on inflammation in older adults with obesity and type 2 diabetes;Experimental Gerontology;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3